HomeInsightsStock Comparison

Csl Finance Ltd vs Novelix Pharmaceuticals Ltd Stock Comparison

Csl Finance Ltd vs Novelix Pharmaceuticals Ltd Stock Comparison

Last Updated on: May 26, 2025

Key Highlights

  • The Latest Trading Price of CSL Finance Ltd is ₹ 322.2 as of 26 May 10:32.
  • The P/E Ratio of CSL Finance Ltd is 0 as of March 2020 .The P/E Ratio of Novelix Pharmaceuticals Ltd is 0 as of March 2020.
  • The Market Cap of CSL Finance Ltd is ₹ 0 crore as of March 2020 .The Market Cap of Novelix Pharmaceuticals Ltd is ₹ 1.57 crore as of March 2020.
  • The revenue of CSL Finance Ltd for the Mar '25 is ₹ 56.68 crore as compare to the Dec '24 revenue of ₹ 53.7 crore. This represent the growth of 5.55% The revenue of Novelix Pharmaceuticals Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 5.3 crore. This represent the decline of -100%.
  • The ebitda of CSL Finance Ltd for the Mar '25 is ₹ 43.33 crore as compare to the Dec '24 ebitda of ₹ 40.19 crore. This represent the growth of 7.81% The ebitda of Novelix Pharmaceuticals Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 0.13 crore. This represent the decline of -100%.
  • The net profit of CSL Finance Ltd changed from ₹ 13.25 crore to ₹ 18.98 crore over 8 quarters. This represents a CAGR of 19.69% The net profit of Novelix Pharmaceuticals Ltd changed from ₹ -0.17 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of -100.00% .
  • The Dividend Payout of CSL Finance Ltd changed from 6.79 % on March 2020 to 8.85 % on March 2024 . This represents a CAGR of 5.44% over 5 yearsThe Dividend Payout of Novelix Pharmaceuticals Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 years.

Share Price

* All values are in Rupees

PE

Market Cap

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About CSL Finance Ltd

  • CSL Finance Ltd (Formerly known Consolidated Securities Limited) was incorporated on December 28, 1992.
  • The Company is engaged in the business of providing the finance facilities to small and medium size business units to fulfill their financial needs.
  • The complete business of CSL can be classified into two broader segments of SME business and Wholesale business.
  • SME business is mainly focused on micro and small business loans to various business entities, which is secured mostly against self-occupied Residential or Commercial properties.
  • Wholesale business is focused on big ticket size loans for working capital requirement of businesses.

About Novelix Pharmaceuticals Ltd

  • Trimurthi Limited was formerly incorporated on December 13, 1994 with the name Trimurthi Securities Ltd. The name of the Company thereafter got changed from Trimurthi Securities Ltd to Trimurthi Drugs & Pharmaceuticals Ltd. In September 2006, as per the Scheme of Arrangement, the erstwhile Trimurthi Drugs & Pharmaceuticals Ltd amalgamated with the Company.
  • Also, the name of the Company was changed to Trimurthi Drugs & Pharmaceuticals Ltd and again to Trimurthi Limited in May, 2016. Initially, the company was engaged in finance and investments in securities.
  • They ceased their operations due to the high volatility in the markets and voluntarily got de-registered as Non-Banking financial company.
  • Thereafter, the company explored the possibilities of entering into pharmaceutical and drug industry by way of diversification.

CSL Finance Ltd News Hub

News

Board of CSL Finance recommends final dividend

CSL Finance announced that the Board of Directors of the Company at its meeting held on 23...

Read more

23 May 2025 19:30

News

CSL Finance announces board meeting date

CSL Finance will hold a meeting of the Board of Directors of the Company on 23 May 2025. P...

Read more

15 May 2025 14:55

News

CSL Finance to declare Quarterly Results

CSL Finance will hold a meeting of the Board of Directors of the Company on 11 February 20...

Read more

04 Feb 2025 15:19

News

CSL Finance schedules board meeting

CSL Finance will hold a meeting of the Board of Directors of the Company on 9 November 202...

Read more

29 Oct 2024 14:42

News

CSL Finance to hold AGM

CSL Finance announced that the Annual General Meeting (AGM) of the company will be held on...

Read more

03 Sep 2024 17:24

News

CSL Finance to convene AGM

CSL Finance announced that the 32th Annual General Meeting (AGM) of the company will be he...

Read more

24 Aug 2024 14:39

Novelix Pharmaceuticals Ltd News Hub

News

Novelix Pharmaceuticals to convene board meeting

Novelix Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 27...

Read more

21 May 2025 16:50

News

Novelix Pharmaceuticals to convene EGM

Novelix Pharmaceuticals announced that an Extra Ordinary General Meeting (EGM) of the Comp...

Read more

15 Apr 2025 10:33

News

Trimurthi to table results

Trimurthi will hold a meeting of the Board of Directors of the Company on 12 February 2025...

Read more

08 Feb 2025 10:47

News

Trimurthi to announce Quarterly Result

Trimurthi will hold a meeting of the Board of Directors of the Company on 13 November 2024...

Read more

09 Nov 2024 17:04

News

Trimurthi revises board meeting date

Trimurthi has revised the meeting of the Board of Directors which was scheduled to be held...

Read more

14 Oct 2024 10:29

News

Trimurthi to hold board meeting

Trimurthi will hold a meeting of the Board of Directors of the Company on 14 October 2024....

Read more

08 Oct 2024 10:44

SWOT Analysis Of Novelix Pharmaceuticals Ltd

Strength

0

S

Weakness

0

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of CSL Finance Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Novelix Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for CSL Finance Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of CSL Finance Ltd and Novelix Pharmaceuticals Ltd

Which company has a larger market capitalization, CSL Finance Ltd or Novelix Pharmaceuticals Ltd?

Market cap of CSL Finance Ltd is 724 Cr while Market cap of Novelix Pharmaceuticals Ltd is 69 Cr

What are the key factors driving the stock performance of CSL Finance Ltd and Novelix Pharmaceuticals Ltd?

The stock performance of CSL Finance Ltd and Novelix Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for CSL Finance Ltd and Novelix Pharmaceuticals Ltd?

As of May 26, 2025, the CSL Finance Ltd stock price is INR ₹318.1. On the other hand, Novelix Pharmaceuticals Ltd stock price is INR ₹27.94.

How do dividend payouts of CSL Finance Ltd and Novelix Pharmaceuticals Ltd compare?

To compare the dividend payouts of CSL Finance Ltd and Novelix Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions